Laboratory for Bioregenerative Medicine and Surgery, Department of Surgery, Weill Cornell Medical College, New York, NY, USA.
J Vasc Surg. 2010 Mar;51(3):707-11. doi: 10.1016/j.jvs.2009.10.049. Epub 2010 Jan 4.
Varicose veins and other vascular abnormalities are common clinical entities. Treatment options include vein stripping, sclerotherapy, and endovenous laser treatment, but all involve some degree of invasive intervention. The purpose of this study was to determine ex vivo the effectiveness of a novel hand-held, battery-operated, high-intensity focused ultrasound (HIFU) device for transcutaneous venous ablation.
The ultrasound device is 14 x 9 x 4 cm, weighs 650 g, and is powered by 4 lithium ion battery packs. An ex vivo testing platform consisting of two different models comprised of sequentially layered skin-muscle-vein or skin-fat-vein was developed, and specimens were treated with HIFU. The tissues were then disassembled, imaged, and processed for histology. The luminal cross-sectional area of vein that had been treated with HIFU and nontreated controls were measured, and the values presented as median and interquartile range (IQR). The values were compared using a Wilcoxon rank-sum test, and statistical significance was set at P < .05.
On gross and histologic examination, veins that had been treated with HIFU showed evidence of coagulation necrosis. The surface of the muscle in direct contact with the vein had a pinpoint area of coagulation, whereas the adjacent fat appeared undisturbed; the skin, fat, and the surface of the muscle in contact with the transducer remained completely unaffected. The cross-sectional area was 3.79 mm(2) (IQR, 3.38-4.22) of the control vein lumen and 0.16 mm(2) (IQR, 0.04-0.39) in those that had been treated with HIFU (P = .0304).
This inexpensive, portable HIFU device has the potential to allow clinicians to easily perform venous ablation in a manner that is entirely noninvasive and without the expense or inconvenience of large, complicated devices. This device represents a significant step forward in the development of new applications for HIFU technology.
静脉曲张和其他血管异常是常见的临床实体。治疗选择包括静脉剥离、硬化治疗和静脉内激光治疗,但所有治疗都涉及一定程度的侵入性干预。本研究的目的是确定一种新型手持式、电池供电、高强度聚焦超声(HIFU)设备用于经皮静脉消融的有效性。
超声设备为 14 x 9 x 4 cm,重 650 g,由 4 个锂离子电池组供电。开发了一个由两个不同模型组成的体外测试平台,这些模型由依次分层的皮肤-肌肉-静脉或皮肤-脂肪-静脉组成,并使用 HIFU 对标本进行处理。然后将组织拆开、成像并进行组织学处理。测量经 HIFU 处理和未经处理的对照静脉的管腔横截面积,并以中位数和四分位距(IQR)表示。使用 Wilcoxon 秩和检验比较值,设定统计学意义为 P <.05。
大体和组织学检查显示,经 HIFU 处理的静脉有凝固性坏死的证据。与静脉直接接触的肌肉表面有一个小点状的凝固区域,而相邻的脂肪看起来未受干扰;皮肤、脂肪和与换能器接触的肌肉表面完全未受影响。对照组静脉腔的横截面积为 3.79 mm 2(IQR,3.38-4.22),而经 HIFU 处理的静脉腔的横截面积为 0.16 mm 2(IQR,0.04-0.39)(P =.0304)。
这种廉价、便携式 HIFU 设备有可能使临床医生能够以完全非侵入性的方式轻松进行静脉消融,而无需使用昂贵且不便的大型复杂设备。该设备代表了高强度聚焦超声技术新应用开发的重要一步。